Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Eduard Teixidor"'
Autor:
Elisabet Cuyàs, Stefano Pedarra, Sara Verdura, Miguel Angel Pardo, Roderic Espin Garcia, Eila Serrano-Hervás, Àngela Llop-Hernández, Eduard Teixidor, Joaquim Bosch-Barrera, Eugeni López-Bonet, Begoña Martin-Castillo, Ruth Lupu, Miguel Angel Pujana, Josep Sardanyès, Tomás Alarcón, Javier A. Menendez
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-17 (2024)
Abstract Fatty acid synthase (FASN)-catalyzed endogenous lipogenesis is a hallmark of cancer metabolism. However, whether FASN is an intrinsic mechanism of tumor cell defense against T cell immunity remains unexplored. To test this hypothesis, here w
Externí odkaz:
https://doaj.org/article/cf58d85bd0c34429bd80f33b1267b08a
Autor:
Josep Sabaté-Ortega, Marc Albert-Carrasco, Carmen Escribano-Ferrer, Gerard Grau-Manrubia, Clàudia Fina-Planas, Carme López-Núñez, Eduard Teixidor-Vilà, Elisabet Bujons-Buscarons, Clàudia Montañés-Ferrer, Núria Sala-González
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Renal cell carcinoma (RCC) is a kidney neoplasm that accounts for 85% of cases and has complex genetic pathways that affect its development and progression. RCC metastasis can occur in 20%-50% of patients and usually affects distant organs. Gastric m
Externí odkaz:
https://doaj.org/article/d2f65bead9a240c2b5eabe8e61d8f218
Autor:
Joaquim Bosch-Barrera, Ariadna Roqué, Eduard Teixidor, Maria Carmen Carmona-Garcia, Aina Arbusà, Joan Brunet, Begoña Martin-Castillo, Elisabet Cuyàs, Sara Verdura, Javier A. Menendez
Publikováno v:
Pharmaceuticals, Vol 15, Iss 1, p 19 (2021)
COVID-19 pathophysiology is caused by a cascade of respiratory and multiorgan failures arising, at least in part, from the SARS-CoV-2-driven dysregulation of the master transcriptional factor STAT3. Pharmacological correction of STAT3 over-stimulatio
Externí odkaz:
https://doaj.org/article/8b7ee1d49b544476a47992a5e8eac169
Autor:
Sara Verdura, Jose Antonio Encinar, Eduard Teixidor, Antonio Segura-Carretero, Vicente Micol, Elisabet Cuyàs, Joaquim Bosch-Barrera, Javier A. Menendez
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6101
Epithelial-to-mesenchymal transition (EMT) may drive the escape of ALK-rearranged non-small-cell lung cancer (NSCLC) tumors from ALK-tyrosine kinase inhibitors (TKIs). We investigated whether first-generation ALK–TKI therapy-induced EMT promotes cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abd3bd54a4947350572e9b7cb77ebf04
https://hdl.handle.net/10481/79391
https://hdl.handle.net/10481/79391
Autor:
Sara Cabrero-de las Heras, Ferran Losa, Xavier Hernández-Yagüe, Gemma Soler, Cristina Bugés, Iosune Baraibar, Andrea Plaja, Eduard Teixidor, Eva Martínez-Balibrea
Publikováno v:
Cancer Research. 82:3489-3489
Introduction: CXC chemokines are a family of small, secreted, chemotactic molecules acting through the binding to their corresponding CXC receptors (CXCRs) and stimulating the migration of cells, most notably those of the immune system. They have bee
Autor:
Eduard Teixidor, Joaquim Bosch-Barrera
Publikováno v:
Journal for Immunotherapy of Cancer
Background Nivolumab, an immune checkpoint inhibitor, has revolutionized the treatment of many cancers. Due to its novel mechanisms of action, nivolumab induces a distinct profile of adverse events. Currently, the incidence and risk of developing ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70bbbe05b520ffa1a7c28f5d66c4da14
https://europepmc.org/articles/PMC6789311/
https://europepmc.org/articles/PMC6789311/
Autor:
Elia Sais, Eduard Teixidor, Joaquim Bosch-Barrera, Javier A. Menendez, Angel Izquierdo, Alejandro Hernández, Carmen Amalia Vásquez, Gloria Sánchez, Walter Carbajal, Sara Verdura
Publikováno v:
Oncotarget, 2018, vol. 9, núm. 68, p. 33043-33049
Articles publicats (D-CM)
Teixidor, Eduard Sais, Elia Vásquez, Carmen Amalia Carbajal, Walter Hernández, Alejandro Sánchez, Gloria Izquierdo i Font, Àngel Xavier Verdura, Sara Menéndez Menéndez, Javier Abel Bosch Barrera, Joaquim 2018 Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Oncotarget 9 68 33043 33049
DUGiDocs – Universitat de Girona
instname
Articles publicats (D-CM)
Teixidor, Eduard Sais, Elia Vásquez, Carmen Amalia Carbajal, Walter Hernández, Alejandro Sánchez, Gloria Izquierdo i Font, Àngel Xavier Verdura, Sara Menéndez Menéndez, Javier Abel Bosch Barrera, Joaquim 2018 Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Oncotarget 9 68 33043 33049
DUGiDocs – Universitat de Girona
instname
Advances in immunotherapy have changed the therapeutic landscape of non-small cell lung cancer (NSCLC), extending overall survival over standard chemotherapy. However, by removing the protection against autoimmunity, immunotherapy can increase immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4efc19ac58e9bdc40657af3096757eff
http://hdl.handle.net/10256/20783
http://hdl.handle.net/10256/20783